Trial Profile
A retrospective, observational study of Abiraterone-acetate and Enzalutamide in patients with advanced prostate cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Feb 2024
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary) ; Enzalutamide (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 03 Oct 2016 New trial record